EN DE
Watch Alto Ingredients Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Alto Ingredients Inc (ALTO) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Alto Ingredients Inc stock $2.17, price $3.74, that is 42.0% below the price, quality 55 out of 100. Rating: strongly overvalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials US

AI Alto Ingredients Inc logo Some data Nov 6, 2026

Alto Ingredients Inc

ALTO · US
Solid, but very expensive

Our calculation puts a fair price 42% below what the stock costs today.

Low debt
Generates free cash flow
Upbeat coverage
Costs just 5.7 times its yearly profit.
Quality 55/100
Thin margins · 5.5% net margin (TTM) · excl. one-off gain FY2025 0.1%
Mixed vs. peers (8/14)
Moderate moat 45/100
Insiders bought $361,250 (6M)
Some data
Fair value $2.17 · Strongly overvalued
Weak Growth (revenue 5y +0.5 %/yr in USD)
⟳ Cyclical
Watch Alto Ingredients Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$7.18 $0.7800 Fair Value $2.17 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

60‑month range $0.7800 – $7.18 · fair‑value band $1.36 – $2.80 · the $3.74 price screens above the $2.17 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 3 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 6, 2026.

Follow Alto Ingredients in your weekly email

Every Wednesday you see whether Alto Ingredients is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Alto Ingredients, Inc. produces, distributes, and markets specialty alcohols, renewable fuel, and essential ingredients in the United States. The company operates in three segments: Marketing and Distribution, Pekin Campus Production, and Western Production.

Show moreShow less

It offers specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and cleaners for health, home, and beauty markets; grain neutral spirits used in alcoholic beverages and vinegar, as well as corn germ used in corn oils in the food and beverage markets; alcohols and other products for paint applications and fertilizers in the industrial and agriculture markets; and essential ingredients, including dried yeast, corn protein meal, corn protein feed, corn germ, distillers grains, and liquid feed for commercial animal feed and pet food applications, as well as yeast and gas liquid CO2 for human consumption.

The company also provides fuel-grade ethanol used as transportation fuel additives and distillers corn oil used as a renewable diesel and biodiesel feedstock, as well as fuel-grade ethanol produced by third parties.

In addition, it offers transportation, storage, and delivery services through third-party service providers. Further, the company operates alcohol production facilities.

It sells ethanol to integrated oil companies and gasoline marketers; essential ingredient feed products to dairies and feedlots; and corn oil to poultry, renewable diesel, and biodiesel customers.

The company was formerly known as Pacific Ethanol, Inc. and changed its name to Alto Ingredients, Inc. in January 2021. Alto Ingredients, Inc. was founded in 2003 and is headquartered in Pekin, Illinois.

Stock analysis

Alto Ingredients Inc (ALTO) currently trades at $3.74, while our model-based Fair Value estimate is $2.17, 42% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of $2.40 per share, and 1 of the 22 models we run sit above the $3.74 price.

Bear case: the Earnings-Based group reads lowest at $0.9400, and 21 of the 22 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $1.36 (bear) to $2.80 (bull), the price of $3.74 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 55/100 (solid quality), in the Basic Materials sector.

Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.

Alto Ingredients Inc reported revenue of $918M in FY2025 versus $1.2B in FY2021, a compound −6.6%/yr. Reported net income was $13.3M in FY2025, compounding −26.7%/yr from FY2021.

Key figures

Market cap $288M Micro · P/E ratio 5.7 · P/S ratio 0.31 · EPS (TTM) $0.6600 · Net margin 5.5% · Return on equity 22.2% · Return on assets (EBIT) −4.2% (5-year average) · Operating margin 3.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 45 out of 100 (medium confidence).

What moves the price

The share trades about 38% below its 52-week high and 171% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at −42%, ALTO screens cheaper than that median.

Fair Value models

Bear $1.36 Fair Value $2.17 Bull $2.80
Price $3.74 · Downside -42.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($0.5660 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $1.64 $2.48 $3.55 80
Growth DCF $1.66 $2.40 $3.30 79
Owner Earnings $2.67 $3.91 $5.51 77
All 23 models by family
DCF Models
FCF DCF $1.64 $2.48 $3.55 80
Owner Earnings $2.67 $3.91 $5.51 77
5Y Revenue Exit $0.8600 $1.33 $1.90 72
5Y EBITDA Exit $1.36 $2.26 $3.27 74
5Y P/E Exit $1.33 $2.19 $3.07 70
10Y Revenue Exit $1.15 $1.62 $2.19 67
10Y EBITDA Exit $1.46 $2.20 $3.12 68
10Y P/E Exit $1.44 $2.16 $2.98 64
Earnings-Based
Graham-Dodd $1.17 $3.27 $4.30 65
Lynch FV $0.6600 $0.9400 $1.22 61
PEG = 1.0 $0.6600 $0.9400 $1.22 57
EPV $0.1700 $0.2600 $0.3300 73
Multiples
P/E Multiple $1.81 $2.41 $3.01 63
P/S Multiple $2.19 $2.92 $3.65 58
P/B Multiple $1.62 $2.17 $2.71 55
EV/EBIT n/a n/a $0.2200 61
EV/EBITDA $0.9500 $1.58 $2.20 65
EV/Revenue n/a $0.2700 $0.6300 50
Asset-Based
NCAV (Graham) $0.1100 $0.1600 $0.2000 55
Growth DCF
Growth DCF $1.66 $2.40 $3.30 79
Economic Profit
Residual Income $2.30 $2.28 $2.38 71
ROIC Compounder $0.1700 $0.2600 $0.3300 71
Growth Earnings
Growth-Adj P/E $1.51 $2.15 $2.80 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 55/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 39
How much profit the company makes from its sales and capital
Quality Growth 60
Are margins and returns getting better?
Cashflow 30
Do the profits arrive as real cash?
Financial strength 42
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 51
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 76
Distance to the 52-week high, does not count
New shares 64
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director bought shares worth $361,250, on Sep 14, 2026.

  • BuyGilbert E NathanDirector3× since May 12, 2026: 85,000 shares, avg. $4.25$361,250Sep 14, 2026

Plus 5 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Revenue growth 1 year
−4.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.5%
Start year 2020 (pandemic). Over 10 years: −2.6% a year
Revenue growth 27 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.6%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
−23.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year−23.4%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−22.7% vs −9.7%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.1% → 1%
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Revenue per share shrinking 12.3%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+26.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+2.1%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +23.7% a year for the price and −0.3% for the forecasts.
Forecast 2026 (sales)+5.3%
Forecast 2027 (sales)+1.1%
Projected 2028 (sales)+1.2%
Projected 2029 (sales)+1.3%
Projected 2030 (sales)+1.4%

ALTO screens overvalued: fair value 42% below the price. Compare with Linde plc →

Recent news

News mood ⓘNews mood, the average tone of recent news (91 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.

Compare Alto Ingredients Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks

Beats the industry median on 8/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 55 · Above median
Fair Value upside −42.0% · Below median
Profitability
Return on equity (12 months) 22.2% · Top 25%
Return on assets 3.4% · Above median
Net margin (12 months) 5.5% · Below median
Operating margin (12 months) 3.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 12.5% · Below median
Balance sheet
Debt / equity 0.26× · Above median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (12 months) 5.7× · Cheapest 25%
P/B 1.18× · Cheaper than median
P/S (12 months) 0.31× · Cheapest 25%
Price / free cash flow (fiscal year) 33.3× · Pricier than median
EV/EBITDA 5.2× · Cheapest 25%
PEG 0.80× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)63 · sector 67
PAST (return on equity)89 · sector 27
HEALTH (low debt)87 · sector 95
DIVIDEND (yield)0 · sector 31

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Nan Ya Plastics Corporation 1303 263.00 TWD 420.80 TWD +60% vs ALTO
Wanhua Chemical Group 600309 ¥72.65 ¥68.03 −6% vs ALTO
Linde plc LIN $515.25 $446.62 −13% vs ALTO
PPG Industries, Inc PPG $122.38 $77.68 −37% vs ALTO
DSM-Firmenich AG DSFIR CHF 100.50 CHF 57.70 −43% vs ALTO
The Sherwin-Williams Company SHW $344.10 $146.37 −57% vs ALTO
Givaudan SA GIVN CHF 4,054 CHF 1,554 −62% vs ALTO
EMS-CHEMIE HOLDING AG EMSN CHF 848.50 CHF 284.63 −66% vs ALTO
Ecolab Inc ECL $300.68 $96.56 −68% vs ALTO
Air Products and Chemicals, Inc APD $304.84 $75.33 −75% vs ALTO

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Alto Ingredients Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Alto Ingredients Inc Fair Value". https://www.fairvalue-calculator.com/stock/ALTO

Frequently asked questions

Is Alto Ingredients Inc (ALTO) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $2.17 versus a price of $3.74, about 42% lower (overvalued).
What is the fair value of ALTO?
Our model-based fair value for Alto Ingredients Inc is $2.17 (as of Nov 6, 2026), built from audited fundamentals. The current price: $3.74.
What is the quality score of ALTO?
Alto Ingredients Inc has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Alto Ingredients Inc (ALTO)?
Our model-based price target is the fair value of $2.17 (as of Nov 6, 2026) from 23 valuation models. Cautious scenario $1.36, optimistic scenario $2.80. It is a calculation from audited fundamentals, not an analyst target.
What is the Alto Ingredients Inc stock forecast for 2026?
Our models put fair value at $2.17, about 42% lower versus a price of $3.74 (overvalued). Cautious scenario $1.36, optimistic scenario $2.80. The calculation is refreshed regularly with new filings.
What is the revenue of Alto Ingredients Inc (ALTO)?
Alto Ingredients Inc reported trailing-twelve-month revenue of about $943M (latest available figure, as of Nov 6, 2026).
Does Alto Ingredients Inc pay a dividend?
Alto Ingredients Inc does not currently pay a dividend.
What growth is priced into Alto Ingredients Inc (ALTO)?
For today's price to be fair in a discounted-cash-flow model, Alto Ingredients Inc would have to grow free cash flow by +26.6 % per year for five years (discount rate 11.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +0.5 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of ALTO use?
Our models discount Alto Ingredients Inc at 11.2 %: a base by market capitalisation (micro), damped by beta 0.13, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Alto Ingredients Inc that is +26.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.2 %) and the same formula as our fair value.
How much growth has Alto Ingredients Inc (ALTO) delivered so far?
Over the past 5 years revenue at Alto Ingredients Inc grew +0.5 % a year. The price currently implies free-cash-flow growth of +26.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Alto Ingredients Inc (ALTO) growing?
The median revenue growth in the sector is +14.3 % a year. That is the yardstick for the growth priced into Alto Ingredients Inc (+26.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Alto Ingredients Inc (ALTO)?
The free-cash-flow yield on the price is 3.00 %: that much free cash flow Alto Ingredients Inc produces per unit of market value. When it exceeds the discount rate of our models (11.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Alto Ingredients Inc (ALTO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Alto Ingredients Inc it is $2.17 per share (as of Nov 6, 2026), against a price of $3.74. It is the blended result of 23 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Alto Ingredients Inc stock overvalued or undervalued in 2026?
As of Nov 6, 2026, ALTO trades above its calculated fair value: price $3.74, fair value $2.17, a gap of about −42% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALTO?
No. The price is what the market pays today ($3.74); the fair value is what the company's own numbers justify ($2.17). For Alto Ingredients Inc the two are $1.57 per share apart. That gap is exactly why we show both numbers side by side.
How much is Alto Ingredients Inc worth?
The market values Alto Ingredients Inc at about $288M (market capitalisation, as of Nov 6, 2026). Per share that is $3.74; our models calculate a fair value of $2.17 per share.
What do the bullish and bearish scenarios say about ALTO?
Our models span a range for Alto Ingredients Inc: cautious scenario $1.36, base $2.17, optimistic $2.80 per share (as of Nov 6, 2026, price $3.74). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ALTO?
Alto Ingredients Inc trades at a price-to-earnings ratio of 5.7 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $2.17 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 311.7 (reported for FY2025: 21.5). Other multiples: PEG 0.8, P/B 1.2, P/S 0.3, EV/EBITDA 5.2.
What is the PEG ratio of ALTO?
The PEG ratio of Alto Ingredients Inc is 0.80 (P/E divided by earnings growth, as of Nov 6, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Alto Ingredients Inc (ALTO)?
Balance-sheet figures for Alto Ingredients Inc (as of Nov 6, 2026): return on equity 22.2%, debt of 0.26 per unit of equity. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is ALTO from its 52-week high?
Alto Ingredients Inc trades at $3.74, about 38% below its 52-week high of $5.99 and 171% above the low of $1.38 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $2.17 is for.
Which stocks are comparable to Alto Ingredients Inc?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Alto Ingredients Inc stock attractive at the current price?
The data as of Nov 6, 2026: price $3.74, calculated fair value $2.17 (−42%), Quality Score 55/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALTO calculated?
We run Alto Ingredients Inc through 23 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $2.17 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Alto Ingredients Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Alto Ingredients Inc (ALTO)?
The closing price on Nov 6, 2026 was $3.74. Our model-based fair value is $2.17, about 42% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Alto Ingredients Inc right now?
The price sits above even our optimistic bull case ($2.80). The favourable scenario is already priced in. Solid but not exceptional quality (55/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($1.36 to $2.80) leaves room in how you read the outcome.

Key figures of Alto Ingredients Inc

How large is the market capitalisation of Alto Ingredients Inc (ALTO)?
The market capitalisation of Alto Ingredients Inc is $288M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Alto Ingredients Inc (ALTO)?
The price-to-sales ratio of Alto Ingredients Inc is 0.31 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Alto Ingredients Inc (ALTO)?
Earnings per share at Alto Ingredients Inc are $0.6600 (price ÷ EPS = P/E 5.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Alto Ingredients Inc (ALTO)?
The net margin of Alto Ingredients Inc is 5.5% (last twelve months), excl. one-off gain FY2025 0.1%. How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Alto Ingredients Inc (ALTO)?
The return on equity (ROE) of Alto Ingredients Inc is 22.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Alto Ingredients Inc (ALTO)?
On an EBIT basis the return on assets of Alto Ingredients Inc is −4.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Alto Ingredients Inc (ALTO)?
The operating margin of Alto Ingredients Inc is 3.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Alto Ingredients Inc (ALTO)?
Revenue at Alto Ingredients Inc is growing +12.5% versus a year earlier (3y avg −11.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Alto Ingredients Inc (ALTO)?
Earnings per share at Alto Ingredients Inc are growing −66.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Alto Ingredients Inc (ALTO) carry?
The net debt of Alto Ingredients Inc is $71.9M (fiscal year 2025, ≈ 8.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Alto Ingredients Inc in the live analysis

One click puts Alto Ingredients Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.